Company News

This press release is posted as a service by Angioplasty.Org

Toshiba Ships 600th Aquilion 64-Row
Detector System Worldwide

Company Reaches Major Milestone for World’s Most Advanced 64/32-Slice CT System

TOKYO, Japan – May 8, 2006 – Toshiba Medical Systems Corporation (TMSC) today announced that it has produced its 600th AquilionTM 64-row detector computed tomography (CT) system, the company’s flagship CT system. This marks a significant milestone for the company’s CT business, which has installed more than 17,000 CT systems in hospitals, imaging centers and medical group practices worldwide, including the Johns Hopkins University School of Medicine, Beth Israel Deaconess Medical Center, Shands at the University of Florida and Cardiovascular Institute of the South (CIS).

According to Peter S. Fail, M.D., cardiologist, CIS, growing patient awareness about advances in diagnostic imaging and physician demand for cutting edge imaging technologies has encouraged many healthcare facilities to acquire 64-slice CT systems to remain competitive and better serve patients. “Our Aquilion 64 is able to quickly deliver the high quality images needed for complex exams and allows us to diagnose a wide range of diseases, such as lung cancer and heart disease, much earlier than before, improving the overall health of our community.”

“Toshiba is very proud of the advancements made in the areas of diagnostic imaging and the significant role our Aquilion 64-row detector system has had on improving diagnosis and treatment of patients with life threatening diseases,” said Toshihiro Rifu, general manager, CT Business Unit, TMSC. “We place significant value on all our customer partners and work closely with them to ensure our technology meets their high standards for clinical accuracy and patient care.”

Toshiba’s Aquilion 64: World’s Most Advanced CT System
Featuring the most advanced multislice CT technologies available, the Aquilion 64 is built on Toshiba's unique 64-row Quantum detector, volumetric imaging capabilities and advanced software applications. The Aquilion is the world’s only true volumetric 64 CT system with 64 detector channels, 3-D cone beam algorithms and volume reconstruction. At the heart of the Aquilion 64- and Aquilion 32-slice systems is the superior multi-detector design that produces high-speed, high-resolution imaging with the best low contrast resolution at the lowest dose. The Quantum detector enables the Aquilion CT scanner to acquire 64 simultaneous slices of 0.5 mm with each 400-millisecond gantry revolution, resulting in precise isotropic imaging of any region of the body in five to 10 seconds. For more information about the Aquilion 64- and 32-slice systems, TAMS and its wide range of medical imaging products, please visit

About Toshiba
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. Toshiba Medical Systems Corporation, an independent group company of Toshiba Corporation, is a global leading provider of diagnostic medical imaging systems and comprehensive medical solutions, such as CT, X-ray, Ultrasound, Nuclear Medicine, MRI and information systems. Toshiba Corporation is a leader in information and communications systems, electronic components, consumer products, and power systems. Toshiba has approximately 161,000 employees worldwide and annual sales of $53 billion.

Aquilion™ is a trademark of Toshiba Medical Systems Corporation.

Source: Toshiba America Medical Systems, Inc.

Angioplasty.Org Home •  PatientCenter

this press release is posted as a reader service by,
an editorially independent informational health site
which has received unrestricted educational grants from
Medtronic plc, TCROSS NEWS, Toshiba America Medical Systems, Volcano Corporation, Terumo Medical Corporation
Cardium Therapeutics, Inc. and Lenox Hill Heart and Vascular Institute of NY
All content, including text, photos and video
©Copyright Venture Digital LLC 1996-2021